The shortage of semaglutide injections (Ozempic, Wegovy) is over, the FDA announced on Friday. The agency, along with maker Novo Nordisk, confirmed that supply now meets or exceeds both the current ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration ...

The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive changes.

Novo Nordisk's (NVO) weight loss therapy Wegovy/Ozempic come out of shortage, but the FDA won't crack down on compounders ...

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

Research is still evolving to identify all the ways semaglutide can affect your overall health. Even so, it probably makes ...

Berberine is a natural compound in flowering plants ... loss with FDA-approved medications. Studies of semaglutide (Wegovy) reveal an average weight loss of 14.7 pounds (6.7 kilograms) with weekly ...

Some people who use semaglutide (Ozempic, others) have noted sagging skin in the buttocks, calling it “Ozempic butt.” While lifestyle modifications may help prevent this weight loss side ...

The implementation of supervised consumption sites or “safe injection sites” as they are commonly called, is pretty much guaranteed to invite controversy no matter where in the world they are ...

Semaglutide helps reduce your appetite and promote satiety by slowing the emptying of your stomach contents. Overeating may cause you to feel full, possibly leading to symptoms like abdominal pain ...

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to the drug major Sun Pharma Labs to conduct the Phase III ...